Published in Nat Genet on June 01, 1996
Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet (2008) 11.80
Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med (2009) 4.96
From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A (2008) 3.39
Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol (2008) 3.22
SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol (2010) 2.73
Molecular diversity and regulation of renal potassium channels. Physiol Rev (2005) 2.56
A comprehensive guide to the ROMK potassium channel: form and function in health and disease. Am J Physiol Renal Physiol (2009) 2.51
Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A (2009) 2.41
Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med (2010) 2.36
The Na+-dependent chloride-bicarbonate exchanger SLC4A8 mediates an electroneutral Na+ reabsorption process in the renal cortical collecting ducts of mice. J Clin Invest (2010) 2.28
Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest (2005) 2.14
Genetic kidney diseases. Lancet (2010) 2.00
WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis. Proc Natl Acad Sci U S A (2005) 1.96
Genetics of human cardiovascular disease. Cell (2012) 1.90
Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. Proc Natl Acad Sci U S A (2008) 1.88
pH gating of ROMK (K(ir)1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome. Proc Natl Acad Sci U S A (1999) 1.85
Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol Biol Cell (2003) 1.79
WNK3 modulates transport of Cl- in and out of cells: implications for control of cell volume and neuronal excitability. Proc Natl Acad Sci U S A (2005) 1.76
New target regions for human hypertension via comparative genomics. Genome Res (2000) 1.75
A panoramic view of gene expression in the human kidney. Proc Natl Acad Sci U S A (2003) 1.72
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol (2011) 1.70
Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family. Pflugers Arch (2003) 1.69
Uncompensated polyuria in a mouse model of Bartter's syndrome. Proc Natl Acad Sci U S A (2000) 1.59
Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J Cell Sci (2011) 1.55
Absence of small conductance K+ channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice. J Biol Chem (2002) 1.49
COMMD1 interacts with the COOH terminus of NKCC1 in Calu-3 airway epithelial cells to modulate NKCC1 ubiquitination. Am J Physiol Cell Physiol (2013) 1.48
Localization of tubular adaptation to renal sodium loss in Gitelman syndrome. Clin J Am Soc Nephrol (2012) 1.48
The Na-K-Cl cotransporters. J Bioenerg Biomembr (1998) 1.45
Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. EMBO J (2003) 1.42
Salt handling and hypertension. J Clin Invest (2004) 1.38
Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities. Future Med Chem (2010) 1.35
Organization of the pronephric kidney revealed by large-scale gene expression mapping. Genome Biol (2008) 1.31
Molecular regulation of NKCC2 in the thick ascending limb. Am J Physiol Renal Physiol (2011) 1.28
Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status. Am J Physiol Renal Physiol (2008) 1.28
Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome. Proc Natl Acad Sci U S A (2011) 1.25
Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases. Biochim Biophys Acta (2010) 1.22
Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome. Proc Natl Acad Sci U S A (2001) 1.16
SPAK differentially mediates vasopressin effects on sodium cotransporters. J Am Soc Nephrol (2013) 1.16
Chloride channel diseases resulting from impaired transepithelial transport or vesicular function. J Clin Invest (2005) 1.13
Thick ascending limb: the Na(+):K (+):2Cl (-) co-transporter, NKCC2, and the calcium-sensing receptor, CaSR. Pflugers Arch (2008) 1.12
Exon loss accounts for differential sorting of Na-K-Cl cotransporters in polarized epithelial cells. Mol Biol Cell (2008) 1.12
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09
Isoforms of renal Na-K-2Cl cotransporter NKCC2: expression and functional significance. Am J Physiol Renal Physiol (2008) 1.08
Rare mutations in the human Na-K-Cl cotransporter (NKCC2) associated with lower blood pressure exhibit impaired processing and transport function. Am J Physiol Renal Physiol (2011) 1.06
Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol (2008) 1.06
Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet (2014) 1.04
The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. Biochem J (2014) 1.02
SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov (2015) 1.02
Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts. Am J Physiol Cell Physiol (2013) 1.01
SORLA/SORL1 functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-) cotransporter 2. Mol Cell Biol (2010) 1.01
Threading through the mizmaze of Bartter syndrome. Pediatr Nephrol (2006) 1.00
Genetics of hypertension: from experimental animals to humans. Biochim Biophys Acta (2009) 1.00
Dose related growth response to indometacin in Gitelman syndrome. Arch Dis Child (1999) 1.00
Pathophysiology of hypercalciuria in children. Pediatr Nephrol (2007) 0.99
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Renal outer medullary potassium channel knockout models reveal thick ascending limb function and dysfunction. Clin Exp Nephrol (2011) 0.97
Physiology and pathophysiology of SLC12A1/2 transporters. Pflugers Arch (2013) 0.96
Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol (2003) 0.95
A founder mutation in the CLCNKB gene causes Bartter syndrome type III in Spain. Pediatr Nephrol (2005) 0.94
Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis. Pediatr Nephrol (2008) 0.94
Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol (2016) 0.94
Novel diuretic targets. Am J Physiol Renal Physiol (2013) 0.93
Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol (2004) 0.93
Altered GABA signaling in early life epilepsies. Neural Plast (2011) 0.92
A mutation linked with Bartter's syndrome locks Kir 1.1a (ROMK1) channels in a closed state. J Gen Physiol (1999) 0.92
Bartter syndrome complicated by immune complex nephropathy. Case report and literature review. Pediatr Nephrol (2003) 0.92
Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p. Am J Hum Genet (1998) 0.91
Diagnosis and management of cerebral salt wasting (CSW) in children: the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). Childs Nerv Syst (2006) 0.91
MAL/VIP17, a new player in the regulation of NKCC2 in the kidney. Mol Biol Cell (2010) 0.90
GABA(A) receptors in normal development and seizures: friends or foes? Curr Neuropharmacol (2008) 0.90
The genetic components of idiopathic nephrolithiasis. Pediatr Nephrol (2010) 0.89
Mutation G47R in the BSND gene causes Bartter syndrome with deafness in two Spanish families. Pediatr Nephrol (2006) 0.88
A consideration of genetic mechanisms behind the development of hypertension in blacks. Curr Hypertens Rep (2013) 0.88
Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls. BMC Nephrol (2014) 0.87
Differential regulation of NFAT5 by NKCC2 isoforms in medullary thick ascending limb (mTAL) cells. Am J Physiol Renal Physiol (2011) 0.87
Gitelman's syndrome (familial hypokalemia-hypomagnesemia). Hippokratia (2007) 0.87
Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion. PLoS One (2013) 0.87
A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism. Pediatr Nephrol (2007) 0.86
Blood pressure and human genetic variation in the general population. Curr Opin Cardiol (2010) 0.85
The macula densa is worth its salt. J Clin Invest (1999) 0.85
Maternal age effects on myometrial expression of contractile proteins, uterine gene expression, and contractile activity during labor in the rat. Physiol Rep (2015) 0.85
Molecular mechanism of a COOH-terminal gating determinant in the ROMK channel revealed by a Bartter's disease mutation. J Physiol (2002) 0.85
The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. J Am Soc Nephrol (2016) 0.84
EAST syndrome: Clinical, pathophysiological, and genetic aspects of mutations in KCNJ10. Rare Dis (2016) 0.84
Genetics of type III Bartter syndrome in Spain, proposed diagnostic algorithm. PLoS One (2013) 0.83
Localization and function of the renal calcium-sensing receptor. Nat Rev Nephrol (2016) 0.83
Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome. J Korean Med Sci (2015) 0.83
In vivo and in vitro splicing assay of SLC12A1 in an antenatal salt-losing tubulopathy patient with an intronic mutation. Hum Genet (2009) 0.83
A compound heterozygous mutation in the BSND gene detected in Bartter syndrome type IV. Pediatr Nephrol (2005) 0.82
Novel insights regarding the operational characteristics and teleological purpose of the renal Na+-K+-Cl2 cotransporter (NKCC2s) splice variants. J Gen Physiol (2005) 0.82
Multiple evolutionarily conserved Di-leucine like motifs in the carboxyl terminus control the anterograde trafficking of NKCC2. J Biol Chem (2012) 0.82
Disease-causing R1185C mutation of WNK4 disrupts a regulatory mechanism involving calmodulin binding and SGK1 phosphorylation sites. Am J Physiol Renal Physiol (2012) 0.82
Progress and future aspects in genetics of human hypertension. Curr Hypertens Rep (2013) 0.82
Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter/Gitelman syndrome based on clinical characteristics. Genet Med (2015) 0.81
NKCC2 is activated in Milan hypertensive rats contributing to the maintenance of salt-sensitive hypertension. Pflugers Arch (2011) 0.81
Pivotal role of the kidney in hypertension. Am J Med Sci (2010) 0.81
Sodium reabsorption in the thick ascending limb in relation to blood pressure: a clinical perspective. Hypertension (2011) 0.81
Antenatal Bartter's syndrome with sensorineural deafness. Indian J Nephrol (2009) 0.81
A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration. Meta Gene (2014) 0.81
Carboxyl-terminal Truncations of ClC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking. J Biol Chem (2015) 0.81
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84
Human hypertension caused by mutations in WNK kinases. Science (2001) 8.71
Molecular basis of human hypertension: role of angiotensinogen. Cell (1992) 6.07
Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science (1999) 6.04
Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet (1996) 5.95
The organization of the histone genes in Drosophila melanogaster: functional and evolutionary implications. Cold Spring Harb Symp Quant Biol (1978) 5.60
Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet (1995) 4.45
Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet (1999) 3.73
Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet (1996) 3.71
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet (1996) 3.58
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet (1997) 3.51
Isolation of specific RNA's using DNA covalently linked to diazobenzyloxymethyl cellulose or paper. Methods Enzymol (1979) 3.04
A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci U S A (1995) 2.69
Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J (1996) 2.39
Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet (2000) 2.38
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science (2000) 2.21
Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int (2001) 2.18
Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet (2000) 2.12
Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet (2002) 2.11
A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A (1995) 2.10
The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis. J Biol Chem (1997) 2.10
Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension (2001) 1.99
Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2004) 1.91
Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet (1998) 1.73
The connecting tubule is the main site of the furosemide-induced urinary acidification by the vacuolar H+-ATPase. Kidney Int (2006) 1.60
Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A (1998) 1.52
False positive mononucleosis screening test results associated with Klebsiella hepatic abscess. Am J Clin Pathol (1990) 1.51
Cloning of the NCX2 isoform of the plasma membrane Na(+)-Ca2+ exchanger. J Biol Chem (1994) 1.48
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1997) 1.46
A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel. EMBO J (1997) 1.46
Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A (1995) 1.43
Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet (1997) 1.39
Confirmation of the assignment of the Sanjad-Sakati (congenital hypoparathyroidism) syndrome (OMIM 241410) locus to chromosome lq42-43. J Med Genet (2000) 1.37
Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet (1992) 1.34
Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation (1992) 1.29
A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med (1996) 1.28
A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem (1995) 1.19
Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens (1996) 1.16
A phenocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteopetrosis with distal renal tubular acidosis. J Med Genet (2003) 1.11
Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med (1992) 1.07
Localization of a gene for autosomal recessive distal renal tubular acidosis with normal hearing (rdRTA2) to 7q33-34. Am J Hum Genet (1999) 1.04
Bartter syndrome and focal segmental glomerulosclerosis: a possible link between two diseases. Pediatr Nephrol (2000) 1.04
Molecular cloning and characterization of Atp6n1b: a novel fourth murine vacuolar H+-ATPase a-subunit gene. J Biol Chem (2001) 1.02
Childhood acute leukemia: a search for occult extramedullary disease prior to discontinuation of chemotherapy. Cancer (1981) 0.99
The molecular basis of inherited hypokalemic alkalosis: Bartter's and Gitelman's syndromes. Am J Physiol (1996) 0.98
Liddle's disease: abnormal regulation of amiloride-sensitive Na+ channels by beta-subunit mutation. Am J Physiol (1996) 0.98
Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1997) 0.97
Additional support for the association of SLITRK1 var321 and Tourette syndrome. Mol Psychiatry (2010) 0.96
Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab (1997) 0.95
An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int (1995) 0.94
Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery (1996) 0.94
Genetic linkage analysis in familial benign hypercalcemia using a candidate gene strategy. I. Studies in four families. J Clin Endocrinol Metab (1992) 0.93
Nephropathy, an underestimated complication of methicillin therapy. J Pediatr (1974) 0.93
[125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature. Br J Pharmacol (1994) 0.93
Ion transporter mutations in Gitelman's and Bartter's syndromes. Curr Opin Nephrol Hypertens (1998) 0.91
Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids (1995) 0.90
Structure of the 5'-flanking regulatory region and gene for the human growth factor-activatable Na/H exchanger NHE-1. J Biol Chem (1991) 0.90
Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension (1998) 0.89
Non-modulation as an intermediate phenotype in essential hypertension. Hypertension (1992) 0.89
Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension (1991) 0.87
Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1999) 0.86
Peptide block of constitutively activated Na+ channels in Liddle's disease. Am J Physiol (1996) 0.86
Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension (2000) 0.83
Severe hypertension, hyperkalemia, and renal tubular acidosis responding to dietary sodium restriction. Pediatrics (1982) 0.83
Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3. Genes Immun (2013) 0.83
Recent advances in the molecular genetics of hypertension. Curr Opin Nephrol Hypertens (1996) 0.82
Multigenic human hypertension: evidence for subtypes and hope for haplotypes. J Hypertens Suppl (1990) 0.81
Absence of amiloride-sensitive sodium absorption in the airway of an infant with pseudohypoaldosteronism. J Pediatr (1999) 0.81
Intensive care and immediate follow-up of children after renal transplantation. Transplant Proc (2001) 0.81
Renal hypoprostaglandism, hypertension, and type IV renal tubular acidosis reversed by furosemide. Ann Intern Med (1983) 0.80
Congenital chloride diarrhea: A single center experience with ten patients. Ann Saudi Med (1995) 0.80
Mutations contributing to human blood pressure variation. Recent Prog Horm Res (1997) 0.80
Mutations in Na(K)Cl transporters in Gitelman's and Bartter's syndromes. Curr Opin Cell Biol (1998) 0.79
Glucocorticoid-remediable aldosteronism. Endocrinol Metab Clin North Am (1994) 0.77
Variation of phenotype in patients with glucocorticoid remediable aldosteronism. J Med Genet (1996) 0.77
Low peripheral plasma renin activity as a critical marker in pediatric hypertension. Pediatr Nephrol (1997) 0.77
Endothelin and the human kidney: a potential target for new drugs. Nephrol Dial Transplant (1994) 0.77
Size and sequence homology of masked maternal and embryonic histone messenger RNAs. Dev Biol (1976) 0.76
Hypertension and convulsions complicating sickle cell anaemia: possible role of transfusion. Ann Trop Paediatr (1984) 0.76
Characterization of peptide and nonpeptide antagonists in human kidney. J Cardiovasc Pharmacol (1995) 0.76
A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity. Hum Genet (1999) 0.76
Counting strokes. Nat Genet (1996) 0.76
Lipoprotein glomerulopathy: a new role for apolipoprotein E? J Am Soc Nephrol (1997) 0.75
Replacing the short ammonium chloride test. Kidney Int (2007) 0.75
Oral treatment of acrodermatitis enteropathica with zinc sulfate. Am J Dis Child (1976) 0.75